iodine has been researched along with Metabolic Syndrome in 16 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The roles of sodium or iodine intake on the metabolic syndrome (MetS) etiology remain controversial." | 8.12 | Urinary sodium, iodine, and volume in relation to metabolic syndrome in Mesoamerican children and their parents. ( Ramirez-Zea, M; Villamor, E; Villatoro-Santos, CR, 2022) |
| "Despite a beneficial role of iodine and seaweed consumption against metabolic syndrome (MetS), which is high in postmenopausal women, few studies investigated such associations in a prospective study." | 8.02 | Dietary iodine, seaweed consumption, and incidence risk of metabolic syndrome among postmenopausal women: a prospective analysis of the Korean Multi-Rural Communities Cohort Study (MRCohort). ( Choi, BY; Kim, MK; Lee, YH; Park, JK; Shin, DH; Shin, J; Shin, MH; Woo, HW, 2021) |
| " Currently, there are limited studies that assessed the relationship of thyroid antibody with the components of metabolic syndrome in adults, especially from iodine-sufficient regions." | 8.02 | Prevalence of Components of Metabolic Syndrome Among Adults with the Presence of Autoimmune Thyroid Condition in an Iodine-Sufficient Region. ( Ma, ZF; Pan, B; Zhang, Q; Zhou, H, 2021) |
| " In the present study, the contribution of different variables, such as the presence of metabolic syndrome (MetS), the volume creatinine clearance (V/CrCl) ratio, the iodine-dose (I-dose)/CrCl ratio, or hypertension, to CI-AKI was evaluated." | 7.88 | Metabolic Syndrome and the Iodine-Dose/Creatinine Clearance Ratio as Determinants of Contrast-Induced Acute Kidney Injury. ( Amiri, A; Arab, M; Ghanavati, R; Riahi Beni, H; Sezavar, SH; Sheykhvatan, M, 2018) |
| "To investigate the prevalence of thyroid nodules (TNs) and to evaluate the association between TNs and metabolic syndrome (MetS) in the moderate iodine intake area of Jiangsu, China." | 7.85 | The Prevalence of Thyroid Nodules and Their Association with Metabolic Syndrome Risk Factors in a Moderate Iodine Intake Area. ( Feng, S; Feng, Y; Liu, C; Mao, X; Xu, S; Zhang, Z; Zhu, Y, 2017) |
| "The aim of this observational, cross-sectional study is to evaluate the relationship between metabolic syndrome and multinodular nontoxic goiter in an inpatient population from a geographic area with moderate iodine deficiency." | 7.78 | Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine deficiency. ( Benvenuto, G; Biondi, B; De Filippo, G; Galante, F; Ippolito, S; Lombardi, G; Mossetti, G; Muscariello, R; Rendina, D; Strazzullo, P; Vivona, CL; Zampa, G, 2012) |
| "This study aimed to examine the relationship between iodine status and metabolic disorders, including components associated with metabolic syndrome, hypertension, hyperglycemia, central obesity, triglyceride abnormalities, and low HDL." | 4.31 | Associations between urinary iodine concentration and the prevalence of metabolic disorders: a cross-sectional study. ( Cai, P; Huang, JF; Jiang, L; Liu, YY; Shen, X; Yang, L; Zhang, XH, 2023) |
| "The roles of sodium or iodine intake on the metabolic syndrome (MetS) etiology remain controversial." | 4.12 | Urinary sodium, iodine, and volume in relation to metabolic syndrome in Mesoamerican children and their parents. ( Ramirez-Zea, M; Villamor, E; Villatoro-Santos, CR, 2022) |
| "Despite a beneficial role of iodine and seaweed consumption against metabolic syndrome (MetS), which is high in postmenopausal women, few studies investigated such associations in a prospective study." | 4.02 | Dietary iodine, seaweed consumption, and incidence risk of metabolic syndrome among postmenopausal women: a prospective analysis of the Korean Multi-Rural Communities Cohort Study (MRCohort). ( Choi, BY; Kim, MK; Lee, YH; Park, JK; Shin, DH; Shin, J; Shin, MH; Woo, HW, 2021) |
| " Currently, there are limited studies that assessed the relationship of thyroid antibody with the components of metabolic syndrome in adults, especially from iodine-sufficient regions." | 4.02 | Prevalence of Components of Metabolic Syndrome Among Adults with the Presence of Autoimmune Thyroid Condition in an Iodine-Sufficient Region. ( Ma, ZF; Pan, B; Zhang, Q; Zhou, H, 2021) |
| " In the present study, the contribution of different variables, such as the presence of metabolic syndrome (MetS), the volume creatinine clearance (V/CrCl) ratio, the iodine-dose (I-dose)/CrCl ratio, or hypertension, to CI-AKI was evaluated." | 3.88 | Metabolic Syndrome and the Iodine-Dose/Creatinine Clearance Ratio as Determinants of Contrast-Induced Acute Kidney Injury. ( Amiri, A; Arab, M; Ghanavati, R; Riahi Beni, H; Sezavar, SH; Sheykhvatan, M, 2018) |
| "To investigate the prevalence of thyroid nodules (TNs) and to evaluate the association between TNs and metabolic syndrome (MetS) in the moderate iodine intake area of Jiangsu, China." | 3.85 | The Prevalence of Thyroid Nodules and Their Association with Metabolic Syndrome Risk Factors in a Moderate Iodine Intake Area. ( Feng, S; Feng, Y; Liu, C; Mao, X; Xu, S; Zhang, Z; Zhu, Y, 2017) |
| "The aim of this observational, cross-sectional study is to evaluate the relationship between metabolic syndrome and multinodular nontoxic goiter in an inpatient population from a geographic area with moderate iodine deficiency." | 3.78 | Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine deficiency. ( Benvenuto, G; Biondi, B; De Filippo, G; Galante, F; Ippolito, S; Lombardi, G; Mossetti, G; Muscariello, R; Rendina, D; Strazzullo, P; Vivona, CL; Zampa, G, 2012) |
| " The United States CF Foundation recently proposed the term cystic fibrosis transmembrane conductance regulator related metabolic syndrome (CRMS) to describe infants with elevated immunoreactive trypsinogen (IRT) on NBS who do not meet diagnostic criteria for CF." | 3.77 | Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome. ( Desai, H; Dixon, M; Platt, M; Ren, CL, 2011) |
| "Incidence of the metabolic syndrome is increasing worldwide, with notable exceptions of some Asian countries where seaweeds are commonly consumed." | 2.74 | Could dietary seaweed reverse the metabolic syndrome? ( Baldeón, ME; Braverman, LE; Chiriboga, DE; Davis, JR; Sarriés, AJ; Teas, J, 2009) |
| "Thyroid disease and metabolic syndrome are both associated with cardiovascular disease." | 1.51 | The Relationship between Thyroid Function and Different Obesity Phenotypes in Korean Euthyroid Adults. ( Jeon, YK; Kim, BH; Kim, EH; Kim, IJ; Kim, JH; Kim, JM; Kim, M; Kim, SS; Kim, YK; Lee, H, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 8 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Villatoro-Santos, CR | 1 |
| Ramirez-Zea, M | 1 |
| Villamor, E | 1 |
| Kim, HJ | 1 |
| Park, S | 1 |
| Park, SJ | 1 |
| Park, HK | 1 |
| Byun, DW | 1 |
| Suh, K | 1 |
| Yoo, MH | 1 |
| Shen, X | 1 |
| Yang, L | 1 |
| Liu, YY | 1 |
| Zhang, XH | 1 |
| Cai, P | 1 |
| Huang, JF | 1 |
| Jiang, L | 1 |
| Park, JK | 1 |
| Woo, HW | 1 |
| Kim, MK | 1 |
| Shin, J | 1 |
| Lee, YH | 1 |
| Shin, DH | 1 |
| Shin, MH | 1 |
| Choi, BY | 1 |
| Pan, B | 1 |
| Zhang, Q | 1 |
| Zhou, H | 1 |
| Ma, ZF | 1 |
| Amiri, A | 1 |
| Ghanavati, R | 1 |
| Riahi Beni, H | 1 |
| Sezavar, SH | 1 |
| Sheykhvatan, M | 1 |
| Arab, M | 1 |
| Su, Y | 1 |
| Zhang, YL | 1 |
| Zhao, M | 1 |
| Zhang, HQ | 1 |
| Zhang, X | 1 |
| Guan, QB | 1 |
| Yu, CX | 1 |
| Shao, SS | 1 |
| Xu, J | 1 |
| Kim, JM | 1 |
| Kim, BH | 1 |
| Lee, H | 1 |
| Kim, EH | 1 |
| Kim, M | 1 |
| Kim, JH | 1 |
| Jeon, YK | 1 |
| Kim, SS | 1 |
| Kim, IJ | 1 |
| Kim, YK | 1 |
| Feng, S | 1 |
| Zhang, Z | 1 |
| Xu, S | 1 |
| Mao, X | 1 |
| Feng, Y | 1 |
| Zhu, Y | 1 |
| Liu, C | 1 |
| Ayturk, S | 1 |
| Gursoy, A | 1 |
| Kut, A | 1 |
| Anil, C | 1 |
| Nar, A | 1 |
| Tutuncu, NB | 1 |
| Teas, J | 1 |
| Baldeón, ME | 1 |
| Chiriboga, DE | 1 |
| Davis, JR | 1 |
| Sarriés, AJ | 1 |
| Braverman, LE | 1 |
| Rendina, D | 1 |
| De Filippo, G | 1 |
| Mossetti, G | 1 |
| Zampa, G | 1 |
| Muscariello, R | 1 |
| Benvenuto, G | 1 |
| Vivona, CL | 1 |
| Ippolito, S | 1 |
| Galante, F | 1 |
| Lombardi, G | 1 |
| Biondi, B | 1 |
| Strazzullo, P | 1 |
| Terlizzi, V | 2 |
| Claut, L | 1 |
| Colombo, C | 1 |
| Tosco, A | 1 |
| Castaldo, A | 1 |
| Fabrizzi, B | 1 |
| Lucarelli, M | 1 |
| Cimino, G | 1 |
| Carducci, C | 1 |
| Dolce, D | 1 |
| Biffi, A | 1 |
| Bonomi, P | 1 |
| Timpano, S | 1 |
| Padoan, R | 2 |
| Bucher, BM | 1 |
| Wright, BA | 1 |
| Weiner, RL | 1 |
| Ren, CL | 1 |
| Desai, H | 1 |
| Platt, M | 1 |
| Dixon, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules Size in Type 2 Diabetes: a 2-years Prospective Multicentric Study[NCT04298684] | Phase 4 | 90 participants (Anticipated) | Interventional | 2021-01-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for iodine and Metabolic Syndrome
| Article | Year |
|---|---|
Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area.
Topics: Adolescent; Adult; Age Factors; Aged; Anthropometry; Case-Control Studies; Endemic Diseases; Female; | 2009 |
Could dietary seaweed reverse the metabolic syndrome?
Topics: Adult; Blood Pressure; Body Weight; Diet; Double-Blind Method; Female; Humans; Iodine; Lipids; Male; | 2009 |
14 other studies available for iodine and Metabolic Syndrome
| Article | Year |
|---|---|
Urinary sodium, iodine, and volume in relation to metabolic syndrome in Mesoamerican children and their parents.
Topics: Adenosine Triphosphate; Adult; Child; Cross-Sectional Studies; Humans; Iodine; Metabolic Syndrome; P | 2022 |
Association between iodine intake and metabolic syndrome in euthyroid adult in an iodine-replete area: a nationwide population-based study.
Topics: Adult; Female; Goiter, Nodular; Humans; Iodine; Male; Metabolic Syndrome; Middle Aged; Nutrition Sur | 2023 |
Associations between urinary iodine concentration and the prevalence of metabolic disorders: a cross-sectional study.
Topics: Adult; Aged; Cross-Sectional Studies; Humans; Iodine; Metabolic Diseases; Metabolic Syndrome; Nutrit | 2023 |
Dietary iodine, seaweed consumption, and incidence risk of metabolic syndrome among postmenopausal women: a prospective analysis of the Korean Multi-Rural Communities Cohort Study (MRCohort).
Topics: Cohort Studies; Female; Humans; Incidence; Iodine; Metabolic Syndrome; Postmenopause; Prospective St | 2021 |
Prevalence of Components of Metabolic Syndrome Among Adults with the Presence of Autoimmune Thyroid Condition in an Iodine-Sufficient Region.
Topics: Adult; China; Female; Humans; Iodine; Male; Metabolic Syndrome; Prevalence; Thyroid Gland; Thyrotrop | 2021 |
Metabolic Syndrome and the Iodine-Dose/Creatinine Clearance Ratio as Determinants of Contrast-Induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Creatine; Creatinine; Female; Human | 2018 |
Association Between Thyroid Nodules and Volume and Metabolic Syndrome in an Iodine-Adequate Area: A Large Community-Based Population Study.
Topics: Adult; Anthropometry; Blood Glucose; Blood Pressure; Body Mass Index; Female; Humans; Insulin Resist | 2019 |
The Relationship between Thyroid Function and Different Obesity Phenotypes in Korean Euthyroid Adults.
Topics: Adult; Aged; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Humans; Iodi | 2019 |
The Prevalence of Thyroid Nodules and Their Association with Metabolic Syndrome Risk Factors in a Moderate Iodine Intake Area.
Topics: Adult; Blood Glucose; China; Cross-Sectional Studies; Eating; Female; Humans; Hypertension; Iodine; | 2017 |
Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine deficiency.
Topics: Aged; Aged, 80 and over; Female; Goiter, Nodular; Hospitalization; Humans; Iodine; Italy; Male; Meta | 2012 |
Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/CF screen-positive, inconclusive diagnosis.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Infant; Infant, Newbor | 2021 |
Elevation of sweat chloride levels in a patient with CFTR-related metabolic syndrome receiving dexmethylphenidate and guanfacine.
Topics: Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Dexmethylphenidate Hydrochloride; Gu | 2022 |
Infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis and acute recurrent pancreatitis: what definition?
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Infant; Metabolic Synd | 2022 |
Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
Topics: Anti-Bacterial Agents; Child, Preschool; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane C | 2011 |